Skip to main content

Table 1 Baseline characteristics of CRVO-ME patients

From: Predictors of visual recovery in patients with macular edema secondary to central retinal vein occlusion after treatment with Conbercept

 

CRVO-ME group

Numble

26

Age (years)

57.70 ± 12.91

Gender (F/M)

11/15

Race

Asian

Duration between initial IVC and baseline (weeks)

4.58 ± 0.31

Number of IVC

3.08 ± 0.21

Fluorescein angiography (ischemic/nonischemic)

9/17

BCVA (logMAR)

1.00 ± 0.73

IOP (mmHg)

12.64 ± 2.13

Mean CST (μm)

747.58 ± 149.38

Mean MV (μm3)

747.58 ± 149.38

Mean PLT (μm)

58.96 ± 8.56

Mean ONLT (μm)

432.58 ± 45.24

Mean DEZ (μm)

2921.04 ± 536.37